T-cell surface glycoprotein CD3

BE0010202Protein groupHumans

T-cell surface glycoprotein CD3 (Humans) is a protein group target in DrugBank. It is acted on by 38 drugs in DrugBank.

Proteins: T-cell surface glycoprotein CD3 delta chain
T-cell surface glycoprotein CD3 epsilon chain
T-cell surface glycoprotein CD3 gamma chain
T-cell surface glycoprotein CD3 zeta chain

What you can answer from here — as of July 21, 2025

38DrugsApproved to experimental, with action, bond type and pharmacological action

87Clinical trialsTrials of drugs acting on it, by phase and status

71+ReferencesStructured and connected to the statements they support

Which approved drugs act on T-cell surface glycoprotein CD3, how selective are they, and which programs against it are still in active trials?

Create a free account or log in to explore the full data card.